Insights

Strategic AI Leader Abzu specializes in in silico disease understanding and drug design powered by the QLattice explainable AI, presenting a strong value proposition for pharma and biotech teams seeking faster, cheaper R&D cycles.

Funding & Growth With €13.3M raised to date and recognition from Gartner and Nordic Startup Awards, Abzu demonstrates investor confidence and market momentum, signaling readiness for partnerships and co-development agreements.

Global Footprint Having offices in Copenhagen and Barcelona and active collaborations with pharma, biotech, and research institutions positions Abzu for cross-border partnerships and regional expansion opportunities.

Tech Stack Fit Cloud-based infrastructure and modern web technologies (AWS, TypeScript, Cloudflare) indicate scalability and potential for enterprise-grade collaboration platforms or data integration services with existing client ecosystems.

Financial Signals Current revenue sits in the startup range, suggesting targeted up-sell options with existing customers, as well as opportunities for larger multi-year contracts through increased project scope in AI-driven drug discovery.

Abzu Tech Stack

Abzu uses 8 technology products and services including Amazon Web Services, Docusaurus, Redux, and more. Explore Abzu's tech stack below.

  • Amazon Web Services
    Cloud Hosting
  • Docusaurus
    Documentation Tools
  • Redux
    Javascript Frameworks
  • D3.js
    Javascript Graphics
  • Swiper
    Javascript Libraries
  • TypeScript
    Programming Languages
  • reCAPTCHA
    Security
  • Essential Addons for Elementor
    Web Platform Extensions

Abzu's Email Address Formats

Abzu uses at least 1 format(s):
Abzu Email FormatsExamplePercentage
First.Last@abzu.aiJohn.Doe@abzu.ai
92%
First.Middle@abzu.aiJohn.Michael@abzu.ai
8%

Frequently Asked Questions

What is Abzu's stock symbol?

Minus sign iconPlus sign icon
Abzu is a publicly traded company; the company's stock symbol is ABZUF.

What is Abzu's official website and social media links?

Minus sign iconPlus sign icon
Abzu's official website is abzu.ai and has social profiles on LinkedInCrunchbase.

How much revenue does Abzu generate?

Minus sign iconPlus sign icon
As of July 2026, Abzu's annual revenue is estimated to be <$1M.

What is Abzu's SIC code NAICS code?

Minus sign iconPlus sign icon
Abzu's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Abzu have currently?

Minus sign iconPlus sign icon
As of July 2026, Abzu has approximately 19 employees across 3 continents, including EuropeAsiaSouth America. Key team members include Cfo: K. S.Head Of Rna Therapeutics: D. T.Co-Founder: V. G. B.. Explore Abzu's employee directory with LeadIQ.

What industry does Abzu belong to?

Minus sign iconPlus sign icon
Abzu operates in the Biotechnology Research industry.

What technology does Abzu use?

Minus sign iconPlus sign icon
Abzu's tech stack includes Amazon Web ServicesDocusaurusReduxD3.jsSwiperTypeScriptreCAPTCHAEssential Addons for Elementor.

What is Abzu's email format?

Minus sign iconPlus sign icon
Abzu's email format typically follows the pattern of First.Last@abzu.ai. Find more Abzu email formats with LeadIQ.

How much funding has Abzu raised to date?

Minus sign iconPlus sign icon
As of July 2026, Abzu has raised $12M in funding. The last funding round occurred on Oct 14, 2022 for $2.4M.

When was Abzu founded?

Minus sign iconPlus sign icon
Abzu was founded in 2018.
Abzu logo

Abzu

Biotechnology ResearchHovedstaden, Denmark11-50 Employees

Abzu is a biotechnology research company focused on understanding diseases and guiding drug design through computational methods. Its work relies on an explainable artificial intelligence framework, the QLattice, which underpins its approach to translating complex data into actionable insights. Founded in 2018, Abzu positions itself as a partner for pharma, biotech, and research institutions, helping to accelerate R&D through in silico analysis and design.

Headquartered in the Copenhagen area of Denmark, Abzu also maintains an office in Barcelona, reflecting its European footprint. The company operates as a small to mid-sized organization within the biotechnology research sector, serving customers across pharmaceutical and academic settings with its AI-enabled research capabilities.

Section iconCompany Overview

Website
abzu.ai
SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
ABZUF
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2018
Employees
11-50

Section iconFunding & Financials

  • $12M

    Abzu has raised a total of $12M of funding over 5 rounds. Their latest funding round was raised on Oct 14, 2022 in the amount of $2.4Mas a grant.

  • <$1M

    Abzu's revenue is estimated to be in the range of <$1M

Section iconFunding & Financials

  • $12M

    Abzu has raised a total of $12M of funding over 5 rounds. Their latest funding round was raised on Oct 14, 2022 in the amount of $2.4Mas a grant.

  • <$1M

    Abzu's revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.